Mode
Text Size
Log in / Sign up

U.S. surveillance report examines gestational diabetes prevalence by maternal age

U.S. surveillance report examines gestational diabetes prevalence by maternal age
Photo by Tiffany Tertipes / Unsplash
Key Takeaway
Interpret U.S. gestational diabetes surveillance data cautiously due to unreported prevalence rates.

A U.S. surveillance report conducted an observational analysis of gestational diabetes prevalence among mothers in the United States. The report specifically examined the percentage of mothers with gestational diabetes categorized by maternal age. No sample size, follow-up duration, or specific intervention or comparator groups were reported.

The primary outcome was the percentage of mothers with gestational diabetes. However, the report did not provide the actual prevalence rates, effect sizes, absolute numbers, p-values, confidence intervals, or direction of any associations. No secondary outcomes were specified. Safety and tolerability data, including adverse events and discontinuations, were not reported.

Key limitations include the absence of reported numerical results, which prevents assessment of the magnitude or significance of any findings. The observational nature of surveillance data means associations cannot establish causality. Funding sources and conflicts of interest were not disclosed. The practice relevance of this report is limited due to the lack of specific, actionable data for clinical decision-making.

Study Details

EvidenceLevel 5
PublishedJan 2023
View Original Abstract ↓
This report describes the percentage of U.S. mothers with gestational diabetes by maternal age.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.